Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Noel Barrett

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Plos One|February 27, 2015
Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigsWalter Wodal, Michael G Schwendinger, Helga Savidis-Dacho, et al.
Plos One|September 3, 2010
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizationsAnnett Hessel, Michael Schwendinger, Daniela Fritz, et al.
Vaccine|August 14, 2012
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose primingMaikel V W van der Velden, Gerald Aichinger, Eva Maria Pöllabauer, et al.
Vaccine|April 6, 2012
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccineHartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, et al.
Vaccine|May 15, 2012
A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolateWalter Wodal, Falko G Falkner, Astrid Kerschbaum, et al.
Vaccine|July 7, 2007
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responsesOtfried Kistner, M Keith Howard, Martin Spruth, et al.
Clinical and Vaccine Immunology : CVI|April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsMaikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Vaccine|October 18, 2011
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trialGerald Aichinger, Hartmut J Ehrlich, John G Aaskov, et al.
Journal of Virology|March 13, 2009
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protectionJosef Mayrhofer, Sogue Coulibaly, Annett Hessel, et al.
The New England Journal of Medicine|June 14, 2008
A clinical trial of a whole-virus H5N1 vaccine derived from cell cultureHartmut J Ehrlich, Markus Müller, Helen M L Oh, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Plos One|February 27, 2015
Immunogenicity and protective efficacy of a Vero cell culture-derived whole-virus H7N9 vaccine in mice and guinea pigsWalter Wodal, Michael G Schwendinger, Helga Savidis-Dacho, et al.
Plos One|September 3, 2010
A pandemic influenza H1N1 live vaccine based on modified vaccinia Ankara is highly immunogenic and protects mice in active and passive immunizationsAnnett Hessel, Michael Schwendinger, Daniela Fritz, et al.
Vaccine|August 14, 2012
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: homologous or heterologous booster response following two dose or single dose primingMaikel V W van der Velden, Gerald Aichinger, Eva Maria Pöllabauer, et al.
Vaccine|April 6, 2012
Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccineHartmut J Ehrlich, Markus Müller, Herwig Kollaritsch, et al.
Vaccine|May 15, 2012
A cell culture-derived whole-virus H9N2 vaccine induces high titer antibodies against hemagglutinin and neuraminidase and protects mice from severe lung pathology and weight loss after challenge with a highly virulent H9N2 isolateWalter Wodal, Falko G Falkner, Astrid Kerschbaum, et al.
Vaccine|July 7, 2007
Cell culture (Vero) derived whole virus (H5N1) vaccine based on wild-type virus strain induces cross-protective immune responsesOtfried Kistner, M Keith Howard, Martin Spruth, et al.
Clinical and Vaccine Immunology : CVI|April 18, 2014
Safety and immunogenicity of a vero cell culture-derived whole-virus H5N1 influenza vaccine in chronically ill and immunocompromised patientsMaikel V W van der Velden, Alexander Geisberger, Thomas Dvorak, et al.
Vaccine|October 18, 2011
Safety and immunogenicity of an inactivated whole virus Vero cell-derived Ross River virus vaccine: a randomized trialGerald Aichinger, Hartmut J Ehrlich, John G Aaskov, et al.
Journal of Virology|March 13, 2009
Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protectionJosef Mayrhofer, Sogue Coulibaly, Annett Hessel, et al.
The New England Journal of Medicine|June 14, 2008
A clinical trial of a whole-virus H5N1 vaccine derived from cell cultureHartmut J Ehrlich, Markus Müller, Helen M L Oh, et al.
Pageof 7